Literature DB >> 16493052

Lack of tyrosine 320 impairs spontaneous endocytosis and enhances release of HLA-B27 molecules.

Susana G Santos1, Antony N Antoniou, Paula Sampaio, Simon J Powis, Fernando A Arosa.   

Abstract

Several lines of evidence suggest that endocytosis of MHC class I molecules requires conserved motifs within the cytoplasmic domain. In this study, we show, in the C58 rat thymoma cell line transfected with HLA-B27 molecules, that replacement of the highly conserved tyrosine (Tyr320) in the cytoplasmic domain of HLA-B27 does not hamper cell surface expression of beta2-microglobulin H chain heterodimers or formation of misfolded molecules. However, Tyr320 replacement markedly impairs spontaneous endocytosis of HLA-B27. Although wild-type molecules are mostly internalized via endosomal compartments, Tyr320-mutated molecules remain at the plasma membrane in which partial colocalization with endogenous transferrin receptors can be observed, also impairing their endocytosis. Finally, we show that Tyr320 substitution enhances release of cleaved forms of HLA-B27 from the cell surface. These studies show for the first time that Tyr320 is most likely part of a cytoplasmic sorting motif involved in spontaneous endocytosis and shedding of MHC class I molecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493052     DOI: 10.4049/jimmunol.176.5.2942

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules.

Authors:  Adriana Magnacca; Irene Persiconi; Elisa Nurzia; Silvana Caristi; Francesca Meloni; Vincenzo Barnaba; Fabiana Paladini; Domenico Raimondo; Maria Teresa Fiorillo; Rosa Sorrentino
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

2.  MHC class I dimer formation by alteration of the cellular redox environment and induction of apoptosis.

Authors:  Dinara Makhadiyeva; Lorraine Lam; Mohammad Moatari; Jasmine Vallance; Ying Zheng; Elaine C Campbell; Simon J Powis
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

3.  EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail.

Authors:  Bryan D Griffin; Anna M Gram; Arend Mulder; Daphne Van Leeuwen; Frans H J Claas; Fred Wang; Maaike E Ressing; Emmanuel Wiertz
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

4.  Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity.

Authors:  Hiroaki Tateno; Hongyi Li; Melissa J Schur; Nicolai Bovin; Paul R Crocker; Warren W Wakarchuk; James C Paulson
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

5.  Suppression of blastogenesis and proliferation of activated CD4(+) T cells: intravenous immunoglobulin (IVIg) versus novel anti-human leucocyte antigen (HLA)-E monoclonal antibodies mimicking HLA-I reactivity of IVIg.

Authors:  M H Ravindranath; P I Terasaki; T Pham; V Jucaud; S Kawakita
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

6.  Mechanism for amyloid precursor-like protein 2 enhancement of major histocompatibility complex class I molecule degradation.

Authors:  Amit Tuli; Mahak Sharma; Haley L Capek; Naava Naslavsky; Steve Caplan; Joyce C Solheim
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

7.  Cryptic protein-protein interaction motifs in the cytoplasmic domain of MHCI proteins.

Authors:  Karla K Frietze; Adlai L Pappy; Jack W Melson; Emily E O'Driscoll; Carolyn M Tyler; David H Perlman; Lisa M Boulanger
Journal:  BMC Immunol       Date:  2016-07-19       Impact factor: 3.615

8.  Divide, Conquer, and Sense: CD8+CD28- T Cells in Perspective.

Authors:  Fernando A Arosa; André J Esgalhado; Carolina A Padrão; Elsa M Cardoso
Journal:  Front Immunol       Date:  2017-01-03       Impact factor: 7.561

Review 9.  HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs.

Authors:  Mepur H Ravindranath
Journal:  J Immunol Res       Date:  2017-05-28       Impact factor: 4.818

Review 10.  Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg.

Authors:  Mepur H Ravindranath; Fatiha El Hilali; Edward J Filippone
Journal:  Vaccines (Basel)       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.